Vascular endothelial growth factor polypeptides
US7160991B1 · kind B1 · utility
0Cited by
7References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 27, 1999 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Dec 21, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to an isolated molecule having vascular endothelial growth factor-like properties and to a genetic sequence encoding same. The molecule will be useful in the development of a range of therapeutics and diagnostics useful in the treatment, prophylaxis and/or diagnosis of conditions requiring enhanced or diminished vasculature and/or vascular permeability. The molecule of the present invention is also a useful effector of primary and central neurons and is capable of inducing astroglial proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.